CD44 Variants and Colorectal Cancer Progression
Author Information
Author(s): DC Gotley, J Fawcett, MD Walsh, JA Reeder, DL Simmons, TM Antalis
Primary Institution: The Queensland Institute of Medical Research
Hypothesis
The study investigates the correlation between the expression of alternatively spliced variants of CD44 and tumor progression in colorectal cancer.
Conclusion
The expression of CD44 variants was not positively correlated with tumor progression or metastasis in colorectal cancer.
Supporting Evidence
- CD44 variant expression was found in both normal and malignant colonic tissues.
- Expression of CD44 variants did not correlate with Dukes' histological stage of the tumor.
- Some benign tumors expressed CD44 variants commonly associated with malignancy.
Takeaway
This study looked at a protein called CD44 in colon cancer and found that just because it's present doesn't mean the cancer is getting worse.
Methodology
The study used immunohistochemistry and RT-PCR to analyze CD44 variant expression in tumor and normal tissue samples from patients.
Limitations
The study did not find a consistent correlation between CD44 variant expression and tumor progression, suggesting a complex role for CD44 in cancer.
Participant Demographics
Patients with colonic neoplasms including adenomatous polyps, carcinomas, and liver metastases.
Want to read the original?
Access the complete publication on the publisher's website